BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 288 filers reported holding BLUEPRINT MEDICINES CORP in Q3 2021. The put-call ratio across all filers is 0.49 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $77,862 | +55.5% | 1,232 | +10.7% | 0.01% | +57.1% |
| Q1 2023 | $50,074 | +2.7% | 1,113 | 0.0% | 0.01% | -12.5% |
| Q4 2022 | $48,761 | -78.8% | 1,113 | -68.1% | 0.01% | -78.9% |
| Q3 2022 | $230,000 | +30.7% | 3,486 | 0.0% | 0.04% | +35.7% |
| Q2 2022 | $176,000 | -21.1% | 3,486 | 0.0% | 0.03% | -6.7% |
| Q1 2022 | $223,000 | -40.2% | 3,486 | 0.0% | 0.03% | -36.2% |
| Q4 2021 | $373,000 | +4.2% | 3,486 | 0.0% | 0.05% | -4.1% |
| Q3 2021 | $358,000 | +16.6% | 3,486 | 0.0% | 0.05% | +16.7% |
| Q2 2021 | $307,000 | -4.4% | 3,486 | +5.6% | 0.04% | -12.5% |
| Q1 2021 | $321,000 | -10.3% | 3,300 | +3.3% | 0.05% | -15.8% |
| Q4 2020 | $358,000 | -24.2% | 3,196 | -37.3% | 0.06% | -36.7% |
| Q3 2020 | $472,000 | +50.8% | 5,095 | +26.9% | 0.09% | +36.4% |
| Q2 2020 | $313,000 | – | 4,015 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 379,090 | $19,037,900 | 17.25% |
| DAFNA Capital Management LLC | 249,521 | $12,530,945 | 3.90% |
| Rock Springs Capital Management LP | 2,685,294 | $134,855,465 | 3.61% |
| Casdin Capital, LLC | 371,378 | $18,650,603 | 2.06% |
| Novo Holdings A/S | 525,000 | $26,365,500 | 1.95% |
| CHI Advisors LLC | 92,888 | $4,664,835 | 1.85% |
| SECTORAL ASSET MANAGEMENT INC | 165,890 | $8,330,996 | 1.62% |
| Avidity Partners Management LP | 751,600 | $37,745,352 | 1.52% |
| EMERALD ADVISERS, LLC | 607,037 | $30,485,393 | 1.48% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 464,321 | $23,318,201 | 1.41% |